This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Thoratec Announces $150 Million Share Repurchase Authorization

Stocks in this article: THOR

PLEASANTON, Calif., Nov. 26, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its Board of Directors has authorized the repurchase of up to $150 million of the company's shares of common stock.  The company's prior authorization expired in early November.  As part of the new authorization, the company has entered into a $75 million Accelerated Share Repurchase (ASR) agreement with J.P. Morgan, which will begin immediately.  The balance of the authorization will be available for utilization at the company's discretion through the end of 2013.

Under the ASR agreement, Thoratec will receive approximately 1.5 million shares at the inception of the program.  The total number of shares ultimately purchased under the agreement will be determined upon final settlement, using the volume-weighted average price of the Company's common stock over a period of time of up to 4.5 months. 

"We remain enthusiastic about the future for Thoratec, based on our market opportunity in both chronic and acute circulatory support, our competitive position, and our pipeline of new technologies.  This repurchase authorization reflects our confidence in the long-term strength of the company, as well as our commitment to a disciplined capital deployment strategy," said Gary F. Burbach, President and Chief Executive Officer.  

"While our top priority is to fund our internal growth initiatives and pursue strategic opportunities, our current cash position coupled with ongoing strong cash flow generation provides us the opportunity to continue returning value to shareholders through additional share repurchase activity," added Taylor C. Harris, Vice President and Chief Financial Officer.

During the first nine months of 2012, Thoratec generated $109 million of cash flow from operating activities, an increase of over 25% relative to the comparable period in 2011.  As of September 29, 2012, the company had approximately $308 million in cash, cash equivalents and investments.

Repurchases will take place on the open market or in privately negotiated transactions from time to time based on market and other conditions.  The program is effective immediately, and except for the ASR, it may be modified, suspended, terminated or extended by the company at any time without prior notice.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs